The AP (5/18, Sherman, Swenson) reports, “The Supreme Court on Monday rejected appeals from pharmaceutical companies that object to negotiating Medicare drug prices with the federal government.” The high court’s “justices did not comment in leaving in place rulings from the federal appeals court in Philadelphia that dismissed the drug manufacturers’ claims.”
Reuters (5/18, Chung) reports drugmakers argued the negotiations illegally force “them to accept steep discounts and” jeopardize innovation. The Supreme Court “justices turned away appeals by Novo Nordisk, AstraZeneca, Janssen Pharmaceuticals, Bristol Myers Squibb, Novartis and Boehringer Ingelheim.” The justices “left in place decisions by lower courts rejecting various legal claims against the drug price negotiation plan.”
Related Links:
— “Supreme Court rejects appeals from drug manufacturers over Medicare price negotiations,”Mark Sherman and Ali Swenson , AP, May 18, 2026